News

  • April 8, 2021

Meeting on the Med 2021 | Tackling challenges in industry standardization

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, highlights that despite the exciting pace of scientific discovery within the...

  • April 8, 2021

Meeting on the Med 2021 | Supply chain management & automation

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, describes the Personalized Therapy Management (PTM) platform, enterprise software that aims...

  • April 8, 2021

Meeting on the Med 2021 | International collaboration in advanced therapies

Publication

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, explains that the scientific community’s response to the COVID-19 pandemic has...

  • April 8, 2021

Meeting on the Med 2021 | What can the field learn from the COVID-19 pandemic?

Publication

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, discusses the lessons that the field of cell and gene therapy...

  • April 1, 2021

Six Cell and Gene Therapy Commercialization Trends

Publication

Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions discuss what to watch in the next 12…

  • March 24, 2021

Exclusive: An industry consortium wants to standardize cell tracking for regenerative meds. Could that avert a disaster?

Publication: Endpoints News

In the fast-moving world of regenerative medicine, the open secret among industry experts is that manufacturing is exceedingly difficult and will take a Herculean effort…

  • March 24, 2021

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Publication: Globe Newswire

SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new…

  • February 17, 2021

How to Evolve and Mature Tech for Biotech and Pharma

Publication: PM360

In the third part of our three series podcast with Vineti, Chief Technology Officer Phil Calvin speaks about the technology that most excites him and…

  • January 13, 2021

Lessons Learned: What to Know About Producing Personalized Therapies

Publication: PM360

In the second of our three-series podcast with Vineti, Chief Commercial Officer Joe DePinto provides a first-hand look at what it takes to actually produce…

  • January 11, 2021

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Publication: Globe Newswire

SAN FRANCISCO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new suite…